Aura Biosciences - AURA Operating profit EBITDA

Brandmark of Aura Biosciences Inc (AURA)

Anticipation regarding the completion of Phase 3 trials for targeted drugs treating rare eye tumors creates powerful growth potential. Visualizing EBITDA dynamics helps determine the entry point, with the indicator currently standing at 0.00. The Aura Biosciences, Inc. (AURA) strategy is based on creating viral particles for the therapy of choroidal melanoma, while patent protection for biologics guarantees long-term monopoly profits in oncology.

AURA - Aura Biosciences Operating profit EBITDA over the range 11/23/2025 - 11/18/2026

Aura Biosciences Inc - analytical breakdowns and key metrics (AURA)

- current quotes and average value forecast:
Analysis of all company metrics:Aura Biosciences, Inc.
Original product of Aura Biosciences

This metric measures the actual liquidity inflow from core operations, eliminating the time lag of quarterly reporting by analyzing real cash flows. The trend in gross operating profit before depreciation and amortization allows for an assessment of the financial stability of Aura Biosciences, Inc. (AURA) during the development of targeted oncology drugs, revealing the company's real capacity to fund research into virus-like particles without accounting adjustments.

Who Aura Biosciences, Inc. competes with

Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Corp - Income before deduction of interest, taxes and amortization|URGN (UroGen Pharma Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Therapeutics Inc. BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS - Profit before interest, taxes and amortization|Operating profit EBITDA DCTH (delcath.com)|Operating profit before depreciation charges Y-mAbs Corp|CADL - Profit before payment of interest, taxes and amortization|Accuray (ARAY) - Operating profit before deduction of amortization|SLS: Operating profit EBITDA|Actuate Therapeutics (ACTU) - Operating profit EBITDA|Operating profit before deduction of amortization CTOR|HURA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Protara Therapeutics (TARA)|Company profit before taxes, interest and amortization FATE|Operating profit EBITDA WHWK (aadibio.com)|Company profit before taxes, interest and amortization TCRX (TScan)|CSBR - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization XBIT (XBiotech Inc)|cel-sci.com (CVM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization OSTX (OS Therapies Incorporated)|Profit before payment of interest, taxes and amortization Radiopharm Theranostics Ltd|Profit before interest, taxes and amortization Artiva Biotherapeutics ARTV|Operating profit EBITDA ANL|VERU - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tempest Therapeutics TPST|xiliotx.com (XLO) - Profit before interest, taxes and amortization|RENB: Operating profit before deduction of amortization|Operating profit before depreciation charges Mural Oncology PLC (MURA)|KAPA (Kairos Pharma Inc) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization OnKure Therapeutics Inc (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization Curis, Inc. (CRIS)|Operating profit EBITDA APLM|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (advanbiomed.com)|GNPX - Operating profit before deduction of amortization|CLDI: Operating profit before deduction of amortization|SBFM - Operating profit EBITDA|Xenetic Biosciences (XBIO) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International